Medicinal composition for preventing and treating cow mastitis, and preparation method thereof

A technology for dairy cow mastitis and composition, which is applied in the directions of drug combination, medical formula, medical preparation containing active ingredients, etc., can solve problems such as affecting people's health, reducing milk quality, affecting treatment effect, etc., and achieves drug curative effect. The effect of highlighting, improving resistance, and enhancing the immune response to viruses

Inactive Publication Date: 2009-12-30
天津诺康动物药业有限公司
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the drugs commonly used in the prevention and treatment of mastitis in dairy cows mainly include macrolides, tetracyclines, lincosamine antibiotics, and fluoroquinolones. Affect the further treatment effect, especially antibiotics will remain in the cows, resulting in a decline in the quality of milk production, seriously affecting people's health
At present, the use of antibiotics in livestock and poultry production has been limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] A pharmaceutical composition for treating dairy cow mastitis, which is composed of the following medicines. Each serving is calculated as 10g. Commercially available dandelion 620g and violadin 350g are pulverized and sieved to make the particle size reach 60 mesh, and mixed with levamisole hydrochloride 30g Uniform and sub-package, that is, the finished product.

Embodiment 2

[0018] A pharmaceutical composition for treating dairy cow mastitis, which is composed of the following medicines, each part is calculated as 10g, 660g of commercially available dandelion and 300g of violadin are pulverized and sieved to make the particle size reach 100 mesh, and mixed evenly with 40g of levamisole hydrochloride And pack it to get the finished product.

Embodiment 3

[0020] A pharmaceutical composition for treating dairy cow mastitis, which is composed of the following medicines. Each serving is calculated as 10g. Commercially available Dandelion 620g violadin 320 is crushed and sieved to make the particle size reach 150 mesh, and mixed with 60g levamisole hydrochloride evenly And pack it to get the finished product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention relates to a medicinal composition for preventing and treating cow mastitis, which is characterized by comprising the following components in portion by weight: 62 to 66 portions of dandelion, 30 to 35 portions of Chinese violets, and 2 to 6 portions of levamisole hydrochloride. A preparation method comprises the steps of weighing dandelion and Chinese violets as raw materials in portion by weight, grinding, sifting, allowing particle size to reach 60 to 200 meshes, evenly mixing the obtained product with levamisole hydrochloride, separately packing and obtaining finished products. The invention has the advantages that the levamisole hydrochloride added to the composition as a component has immunoregulation and immunity excitement functions, restores suppressed immune functions to normal so as to improve immunity, and plays a role in clearing heat, releasing toxin and treating cow mastitis through the Chinese-Western medicament combination with three Chinese medicaments in the prior prescription. The composition can inhibit the replication of various viruses, can enhance the immune response of bodies to stomatitis viruses, has synergistic effects, prevents infection, improves disease-resistant capability, has outstanding therapeutic effects, no drug residue, no toxic side effects and low cost, and can effectively guarantee the food safety of dairy products for people.

Description

technical field [0001] The invention belongs to medicine for cows, in particular to a medicine composition for treating cow mastitis and a preparation method thereof. Background technique [0002] Cow mastitis, also known as mastitis, is one of the most common, most difficult and costly diseases of dairy cows. 20-60% of lactating cows suffer from this disease. The disease is mainly a mammary gland disease caused by a variety of non-specific pathogenic microorganisms and the milk of cows shows obvious clinical symptoms. However, among many pathogens, bacterial infection is the main cause of cow mastitis. The occurrence of this disease will reduce the milk production of cows, and when it is serious, it will cause blind teats, affect the life-long milk production, and even cause sepsis so that the cows will lie down and be forced to be eliminated. There is still no effective radical cure and effective vaccine for this at present, and only antibacterial drugs are used to preven...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/86A61P15/14A61K31/429
Inventor 赵会芹
Owner 天津诺康动物药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products